Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Enterome (France) | Researchclopedia

Back to institutions

Enterome (France)

Paris, Île-de-Francecompany

96

Works

6,404

Citations

49

h-index

Top Research Topics

Gut microbiota and health Immunotherapy and Immune Responses CAR-T cell therapy research

Top Researchers

Harry Sokol Harvard University

657 works63,130 citationsh-index: 100

Recent Research

Abstract DP305: Impact of Multidimensional Histological Clot Composition on the Selection of First Line Technique and Angiographic Outcomes During Mechanical Thrombectomy: A Comprehensive Systematic Review and Meta-Analysis

Mohamed Doheim,David Bouchez,et al.

20260 citations

Cancer Immunotherapy and Biomarkers

Cancer Research and Treatments

Clostridium difficile and Clostridium perfringens research

Genomics and Phylogenetic Studies

Inflammatory Bowel Disease

Diet and metabolism studies

Probiotics and Fermented Foods

Liver Disease Diagnosis and Treatment

vaccines and immunoinformatics approaches

Mark Tremelling

69 works24,641 citationsh-index: 29

Jennifer Martinez National Institutes of Health

135 works23,038 citationsh-index: 49

João Pedro de Magalhães University of Lisbon

298 works18,571 citationsh-index: 74

Jean–François Fléjou Inserm

445 works17,741 citationsh-index: 65

Jan Fagerberg University of Oslo

295 works17,150 citationsh-index: 54

EO2463 (EO) peptide immunotherapy combined with rituximab (R) for first-line treatment of low-tumor burden follicular lymphoma (FL): A feasibility evaluation in Study EONHL1-20/sidney (NCT04669171)

Stephen D. Smith,Francesc Bosch,et al.

20250 citations

EO2463 (EO) peptide immunotherapy in patients (pts) with newly diagnosed asymptomatic follicular lymphoma (FL) and marginal zone lymphoma (MZL): Study EONHL1-20/sidney (NCT04669171) primary endpoint lugano objective response analysis

José C. Villasboas,Reid W. Merryman,et al.

20250 citations

CTIM-15. EO2401 PEPTIDE IMMUNOTHERAPY + NIVOLUMAB +/- BEVACIZUMAB IN FIRST RECURRENT GLIOBLASTOMA: TREATMENT STRATEGY OPTIMIZATION IN THE PHASE 1/2 STUDY EOGBM1-18 / ROSALIE (NCT04116658)

David A. Reardon,Ahmed Idbaïh,et al.

20250 citations

Impact of sporting, cultural and social events on emergency admissions: a retrospective multicenter study

Maria Fritsch,Cyrielle Brossard,et al.

20250 citations

The gut microbiota protein BOC1 exhibits immune checkpoint inhibitor-like activity by inhibiting myeloid-derived suppressor cell differentiation

Laureen Bardouillet,María Lucía Orsini Delgado,et al.

20250 citations